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Abstract
Background: Behcet’s disease (BD) is a chronic immune-mediated, inflammatory disorder which may affect a
number of different systems (oral and genital mucosa, eyes, skin, vascular district, joints, gastrointestinal tract
and nervous system). Neurological manifestations are present in 5–10%, and gastrointestinal tract involvement
in 10–15% of cases. The simultaneous involvement of two systems, neurological and gastrointestinal tract, is
very rare and represents the aim of our case report.
Case presentation: We describe a case of a 12-year-old girl with neurological (endocranial hypertension,
papilledema, retinal vasculitis) and gastrointestinal tract (terminal ileum and cecum inflammation) involvement
and with a history of recurrent oral aphthosis; therefore, according to both International Criteria for Behcet’s
Disease (ICBD) and Paediatric Behcet’s Disease criteria (PEDBD) the diagnosis of BD was confirmed.
Conclusions: This case report is one of the few described in literature with simultaneous involvement of the two
systems, neurological and gastrointestinal tract, in paediatric BD. The diagnosis is really difficult because there is no
specific diagnostic test. We think that our clinical case should help clinicians to suspect a BD with an unusual onset.
Background
Behçet disease (BD) was first described by the Turkish
dermatologist Hulusi Behçet in 1937 as a syndrome
with oral and genital ulcerations and ocular inflammation
[1, 2]. It is defined as a rare multi-systemic inflammatory
disease with unknown etiology and chronic recurrent
pattern, characterized by oral and genital aphthosis/ulcers
with ocular, skin, articular, vascular, gastrointestinal
and/or central nervous system lesions. Furthermore, it
has many clinical characteristics that are similar to
inflammatory bowel diseases (IBD). BD is included both
in vasculitis and auto-inflammatory disease classifica-
tions [3]. It is considered a vasculitis with involvement
of vessels of all kinds and sizes [4] and it is defined as
a multifactorial auto-inflammatory syndrome [5]. The
highest prevalence of BD has been reported in Japan,
Iran, Turkey (Silk Route), more rarely occurring in
Western countries. Usually, BD onset is found in young
adults, around 20–35 years, with no difference between
sexes, but a worse disease course in the male popula-
tion. BD is rare in paediatric age and the prevalence is
unknown. It is difficult to make diagnosis under
16 years due to the heterogeneous clinical picture, such
as oral and genital ulcers, erythema nodosum, superfi-
cial thrombophlebitis, acne and arthritis [6, 7]. Factors
that contribute to the pathogenesis of BD include the
host’s genetic profile and immune system, and environ-
mental factors such as the gut microbiota. BD has an
important genetic component, and thus the frequency
of familial cases is around 10 to 50% [8]. HLA-B51 is
associated with BD, being predominant in affected
males with a higher prevalence of genital ulcers, ocular
and skin manifestations and decreased gastrointestinal
involvement [9]. Diagnosis of BD is based on clinical
criteria. The most widely used diagnostic criteria for
adult onset disease are from the International Behcet’s
Study Group (ISG). In 2014, new criteria for BD
diagnosis were proposed, called ICBD, that include two
additional clinical criteria, neurological and vascular
involvement, permitting diagnosis even without the
presence of oral aphthous lesions which were consid-
ered mandatory in the previous ISG classification. An
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international expert consensus group, the pediatric BD
(PEDBD), has recently proposed a new set of criteria
for the classification of BD in children [10]. PEDBD in-
clude the following features: recurrent oral aphtosis (at
least 3 attacks/year), genital ulceration (typically with
scar), skin involvement (necrotic folliculitis, acneiform
lesions, erythema nodosum), ocular involvement (anter-
ior or posterior uveitis, retinal vasculitis), neurological
signs (with the exception of isolated headaches), vascu-
lar signs (venous thrombosis, arterial thrombosis, arter-
ial aneurysm). All the clinical symptoms have the same
importance (1 point) and three of them are required to
classify a patient as having pediatric BD. Unlike the ISG
and ICBD criteria, in PEDBD the pathergy test is not
included. In children the symptoms are few to apply
any classification. Because of the exiguity of clinical
manifestations in the pediatric population, in most case
the diagnosis is based on the physician’s experience. A
substantial difference between the ISG and the PEDBD/
ICBD criteria are that oral aphthosis is the mandatory
criterion, while in the other two classification, it is pos-
sible to make diagnosis of BD even without the pres-
ence of oral aphtosis. The treatment of BD is difficult
and is based on disease activity and severity including
different medical therapies (corticosteroids, colchicine,
immunosuppressive and biological drugs).
Case presentation
A 12-year-old child was admitted to our Unit after
2 weeks of persistent symptoms of headache, nausea
and abdominal pain. Physical examination revealed stiff
neck, left oculomotor paresis, left facial nerve paresis,
left hemiparesis; laboratory tests showed a neutrophilic
leukocytosis, thrombocytosis, increased C-reactive protein
and a raised erythrocite sedimentation rate. Ophthalmo-
logical exam and fundus evaluation showed a bilateral
papilledema and retinal vasculitis with loss of visual acuity.
Brain computed tomography (CT) scan was performed
and was normal. A brain magnetic resonance imaging
(MRI) confirmed papilledema and showed a mild inver-
sion of the optic papilla on the optic disk on both sides,
with prominent subaracnoid space around the optic
nerves, and a partially empty sella turcica. These findings
appeared compatible with a condition of Pseudotumor
cerebri (PTC) (Fig. 1). Therefore, a lumbar puncture was
performed and revealed elevated cerebrospinal fluid pres-
sure and oligoclonal bands of IgG, which were found also
in the blood serum. Infective diseases were excluded. In
the following days, abdominal pain and rectal bleeding
appeared. Faecal calprotectin was increased, ANCA and
ASCA autoantibodies were negative, HLA B51 was not
found; a pathergy test was performed and the results were
negative. Abdominal ultrasound revealed thickening of
the ascending colon walls and cecal area, with a maximum
thickness of about 6 mm with the loss of regular parietal
stratification, and a subsequent abdominal CT docu-
mented wall thickening of the last ileal loop and the
proximal of the blind, which is associated with edematous
imbibition of surrounding fatty tissue. An endoscopic
evaluation was performed: ileo-colonscopy showed round-
shaped ulcers with active bleeding in the ileal region and
esophagogastroduodenoscopy showed gastric aphtous
lesions. In addiction, a history of recurrent oral minor
aphtosis (3-4 episodes/year) was highlighted about two
years before; then, according to ICBD and PEDBD cri-
teria, the diagnosis of BD with intestinal and neuro-
logical involvement was suspected and three-day therapy
with endovenous methylprednisolone (1 gr/die) was
started, followed by oral corticosteroid and cyclophos-
phamide replaced after three months by mycophenolate
mofetil. Clinical symptoms gradually improved with re-
gression of gastrointestinal bleeding and complete re-
mission of the neurological manifestations of the PTC.
Histological findings of the ileal mucosa showed swollen
vascular endothelial cells of capillary vessels and small
blood vessels, fibrotic necrosis of small vessels and
bleeding, diffuse perivascular lymphocytic in mucosa
and submucosa suggestive of intestinal vasculitis (Fig. 2).
Treatment with corticosteroids and mycophenolate mofe-
til was followed for several months with the disappearance
of neurological and gastrointestinal symptoms. The ste-
roids dose was gradually reduced, with subsequent relaps-
ing of gastrointestinal symptoms. A magnetic resonance
enterography was performed to evaluate the small-bowel
and showed marked inflammatory changes of the terminal
ileum and cecum with diffuse bowel-wall thickening and
polypoid appearance. Localized fibrofatty proliferation and
mesenteric vascular engorgement were also detected.
Treatment with Adalimumab was started with transient
improvement. After three months, the gastrointestinal
symptoms relapsed again and the patient was submitted
to urgent terminal-ileum resection for terminal ileal per-
foration (Fig. 3). Histological examination of the surgically
resected intestinal specimens showed thickening of the
vessel wall and infiltration of inflammatory cells (i.e. neu-
trophils and mononuclear cells) in the vascular wall and
perivascular area, compatible with submucosal phlebitis
pattern. No post-operative complications were observed,
the therapy with adalimumab was suspended and main-
tenance therapy with azathioprine was started. No post-
operative primary intestinal recurrence has appeared in
the following 2 years, during which the patient didn’t
presented oral aphtosis any more.
Discussion
This clinical case demonstrates that BD is not a rare
clinical entity in the paediatric population. Neurological
involvement affects 5–10% of patients, is quite common
Gallizzi et al. Italian Journal of Pediatrics  (2017) 43:33 Page 2 of 5
Fig. 2 Histology from the ileocecal valve showing inflammatory cell
infiltration and loss of glands Hematoxylin-eosin x 100
Fig. 3 Introperative view of the terminal ileum perforation (arrow)
with localized peritoneal and omental reaction
Fig. 1 Brain Magnetic Resonance Imaging MRI TSE sequences of the patient showing mild inversion of the optic papilla on the optic disk on
both sides, with prominent subaracnoid space around the optic nerves (a-b), and a partially empty sella turcica (c-d)
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in adults, and rarely occurs in children and adolescents
[11, 12]. It involves the central nervous system, with
parenchymal and non-parenchymal lesions, and rarely
the peripheral nervous system. A parenchymal pattern
includes focal parenchymal lesions and aseptic meningo-
encephalitis while non-parenchymal or vascular lesions
include venous thrombosis and arterial vasculitis [13].
Our clinical case had symptoms of acute meningitis with
stiff neck and headache, signs of peripheral nervous
system involvement, such as left hemiparesis with palpe-
bral ptosis, non-parenchymal findings of idiopathic
intracranial hypertension (papilledema, visual impair-
ment, headache) and ocular alterations (retinal vascu-
litis). In intestinal BD, the terminal ileum and cecum
are the main sites involved and include volcano-type
and aphthous type of lesions. Intestinal BD shares
clinical course, endoscopic and histologic features with
IBD, particularly Crohn’s disease (CD) [14–17]. In this
case report, endoscopic evaluation showed round-
shaped ulcers with active bleeding in the ileal region
with gastric aphthous lesions. This macroscopic pattern
can be differentiated from CD where longitudinal
ulcers are discontinuous with mucosal edema, focal
and diffuse erythema, nodular lesions, erosions and
ulcers [18]. Neutrophilic infiltration, lymphocyte ag-
gregation of the surrounding vessels, and vascular
proliferation can be considered as histopathological
characteristics of intestinal BD [19]. Ulcers in BD
tend to perforate at multiple sites, with the need for
surgery in up to 50% of patients [20]. Recurrent ul-
ceration of the stoma is a relatively common compli-
cation, as the recurrence of disease adjacent to or at
surgical anastomosis. Most of these recurrent ulcers
appear within two years of resection [21].
Conclusions
Although there is no specific diagnostic test for BD,
diagnostic clinical criteria are available. Rheumatologists
and gastroenterologists are mainly involved in the diag-
nosis and management of this disease. We believe that
the report of this clinical case can be useful to paediatri-
cians to make an appropriate differential diagnosis between
BD and CD.
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